# Evaluation of the Relative Bioavailability and Food Effect of GDC-9545 in Healthy Females of Non-Childbearing Potential

> **NCT04274075** · PHASE1 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 18 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** GDC-9545 Tablet, Fasted: Treatment A
- **DRUG:** GDC-9545 Capsule, Fasted: Treatment B
- **DRUG:** GDC-9545 Capsule, Fed: Treatment C

## Key facts

- **NCT ID:** NCT04274075
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-06
- **Primary completion:** 2020-04-16
- **Final completion:** 2020-04-16
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2021-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04274075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04274075, "Evaluation of the Relative Bioavailability and Food Effect of GDC-9545 in Healthy Females of Non-Childbearing Potential". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04274075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*